HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral Antibiotics Reduce Intestinal Necrosis in Acute Mesenteric Ischemia: A Prospective Cohort Study.

AbstractOBJECTIVES:
To identify treatments likely to prevent progression towards irreversible transmural intestinal necrosis (ITIN) in acute mesenteric ischemia (AMI).
METHODS:
Prospective observational cohort study from a French intestinal stroke center. Multivariate analysis using a time-dependent Cox regression model.
RESULTS:
Between 2009 and 2015, 67 patients with AMI were included. ITIN occurred in 34% of patients and mortality was 13%. Oral antibiotics was independently associated with a decreased risk of ITIN (HR: 0.16 (95% CI = 0.03-0.62); p = 0.01).
CONCLUSIONS:
By decreasing luminal bacterial load and translocation, oral antibiotics in addition to early revascularization might reduce progression of AMI to ITIN.
AuthorsAlexandre Nuzzo, Leon Maggiori, Catherine Paugam-Burtz, Dominique Cazals-Hatem, Maxime Ronot, Audrey Huguet, Aymeric Becq, Yves Castier, Emmanuel Weiss, Aurélie Plessier, Alexy Tran-Dinh, Francisca Joly, Yves Panis, Yoram Bouhnik, Nathalie Gault, Olivier Corcos
JournalThe American journal of gastroenterology (Am J Gastroenterol) Vol. 114 Issue 2 Pg. 348-351 (02 2019) ISSN: 1572-0241 [Electronic] United States
PMID30538292 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Anticoagulants
  • Proton Pump Inhibitors
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Anti-Bacterial Agents (therapeutic use)
  • Anticoagulants (therapeutic use)
  • Blood Transfusion
  • Cohort Studies
  • Disease Progression
  • Female
  • Fluid Therapy
  • Humans
  • Intestines (pathology)
  • Male
  • Mesenteric Ischemia (pathology, therapy)
  • Mesenteric Vascular Occlusion (therapy)
  • Middle Aged
  • Necrosis
  • Proportional Hazards Models
  • Prospective Studies
  • Proton Pump Inhibitors (therapeutic use)
  • Vascular Surgical Procedures

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: